- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- 18.1 Structure and function
- 18.2 The clinical presentation of respiratory disease
- 18.3 Clinical investigation of respiratory disorders
- 18.4 Respiratory infection
- 18.5 The upper respiratory tract
- 18.6 Allergic rhinitis
- 18.7 Asthma
- 18.8 Chronic obstructive pulmonary disease
- 18.9 Bronchiectasis
- 18.10 Cystic fibrosis
- 18.11 Diffuse parenchymal lung diseases
- 18.12 Sarcoidosis
- 18.13 Pneumoconioses
- 18.14 Miscellaneous conditions
- 18.14.1 Diffuse alveolar haemorrhage
- 18.14.2 Eosinophilic pneumonia
- 18.14.3 Lymphocytic infiltrations of the lung
- 18.14.4 Hypersensitivity pneumonitis
- 18.14.5 Pulmonary Langerhans’ cell histiocytosis
- 18.14.6 Lymphangioleiomyomatosis
- 18.14.7 Pulmonary alveolar proteinosis
- 18.14.8 Pulmonary amyloidosis
- 18.14.9 Lipoid (lipid) pneumonia
- 18.14.10 Pulmonary alveolar microlithiasis
- 18.14.11 Toxic gases and aerosols
- 18.14.12 Radiation pneumonitis
- 18.14.13 Drug-induced lung disease
- 18.15 Chronic respiratory failure
- 18.16 Lung transplantation
- 18.17 Pleural diseases
- 18.18 Disorders of the thoracic cage and diaphragm
- 18.19 Malignant diseases
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine
Lipoid (lipid) pneumonia
- Chapter:
- Lipoid (lipid) pneumonia
- Author(s):
S. J. Bourke
- DOI:
- 10.1093/med/9780198746690.003.0429
Lipoid pneumonia is an unusual form of lung disease resulting from the accumulation of lipids in the alveoli, where they provoke a foreign body reaction with associated inflammation and sometimes local fibrosis. The lipids may be endogenous or exogenous in origin, and the clinical mechanisms and circumstances differ accordingly. Exogenous lipoid pneumonia occurs when animal, vegetable, or mineral oils are aspirated or inhaled into the lungs, provoking a foreign body reaction with chronic inflammation. Typical symptoms are cough and breathlessness. The chest radiograph and CT may show interstitial thickening, with areas of consolidation that may coalesce into a mass (paraffinoma) which simulates carcinoma. Bronchoalveolar lavage and biopsy show lipid-laden macrophages. In endogenous lipoid pneumonia the lipids are derived from surfactant and cholesterol released from decaying cells distal to bronchial obstruction.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- 18.1 Structure and function
- 18.2 The clinical presentation of respiratory disease
- 18.3 Clinical investigation of respiratory disorders
- 18.4 Respiratory infection
- 18.5 The upper respiratory tract
- 18.6 Allergic rhinitis
- 18.7 Asthma
- 18.8 Chronic obstructive pulmonary disease
- 18.9 Bronchiectasis
- 18.10 Cystic fibrosis
- 18.11 Diffuse parenchymal lung diseases
- 18.12 Sarcoidosis
- 18.13 Pneumoconioses
- 18.14 Miscellaneous conditions
- 18.14.1 Diffuse alveolar haemorrhage
- 18.14.2 Eosinophilic pneumonia
- 18.14.3 Lymphocytic infiltrations of the lung
- 18.14.4 Hypersensitivity pneumonitis
- 18.14.5 Pulmonary Langerhans’ cell histiocytosis
- 18.14.6 Lymphangioleiomyomatosis
- 18.14.7 Pulmonary alveolar proteinosis
- 18.14.8 Pulmonary amyloidosis
- 18.14.9 Lipoid (lipid) pneumonia
- 18.14.10 Pulmonary alveolar microlithiasis
- 18.14.11 Toxic gases and aerosols
- 18.14.12 Radiation pneumonitis
- 18.14.13 Drug-induced lung disease
- 18.15 Chronic respiratory failure
- 18.16 Lung transplantation
- 18.17 Pleural diseases
- 18.18 Disorders of the thoracic cage and diaphragm
- 18.19 Malignant diseases
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine